You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Clinical Trial Search Results

Baystate has clinical trials in several medical specialties. Clinical trials can help our patients by making advanced care available to them right in their communities.

Is volunteering for a clinical trial right for you? Learn more.

Page 4 of 8 | Results 31 - 40 of 73

Electronic Cigarette Use During Pregnancy

Heather Sankey, MD
OB Gyn, Pregnancy

  • Baystate Medical Center, 759 Chestnut Street, Springfield, MA
  • Baystate Wing Hospital, 40 Wright Street, Palmer, MA
  • Baystate Mary Lane Outpatient Center, 85 South Street, Ware, MA

Recruiting

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Estudio PARTO - A Randomized Trial of a Postpartum Diabetes Prevention Program for Hispanic Women

This study compares general health and wellness to nutritional and physical activity lifestyle changes as means to delay or prevent postpartum type two diabetes in Hispanic women who are less than 30 weeks pregnant.

Corina Schoen, MD
Diabetes, OB Gyn, Obesity

Baystate Medical Center
Wesson Women's Clinic
759 Chestnut Street
Springfield, MA

Evaluating how certain compounds (phthalates) affect embryonic development after fertilization

The purpose of this study is to better understand how phthalates, compounds that disrupt hormones, affect embryonic development after fertilization.

Cynthia Sites, MD
Pregnancy

Baystate Medical Center, 759 Chestnut Street, Springfield, MA

Evaluating the safety and effectiveness of Restorelle Direct Fix and surgery to repair pelvic organ prolapse

Information on the safety and effectiveness of Restorelle Direct Fix and the surgical procedure to implant Restorelle polypropylene mesh in the repair of pelvic organ prolapse will be collected in this study.
Keisha Jones, MD
OB Gyn

Baystate Urogynecology
Baystate Northampton OB/GYN
325 King St
Northampton, MA 01060

GEMINI 1 - A Phase III multicenter trial evaluating the efficacy, safety, and tolerability of dolutegravir plus lamivudine (study drugs) compared to dolutegravir plus tenofovir/emtricitabine in HIV-1

The purpose of this study is to compare safety, efficacy, and tolerability of a two drug regimen of dolutegravir (DTG) plus (+) lamivudine (3TC) administered once daily to the DTG plus Tenofovir [TDF]/Emtricitabine [FTC] fixed dose combination [FDC] administered once daily in human immunodeficiency virus (HIV) 1 infected adult subjects that have not previously received antiretroviral therapy. The study is designed to demonstrate the non-inferior antiviral activity of DTG plus 3TC regimen to that of DTG plus TDF/FTC FDC.
Dr. Daniel Skiest
Infection, HIV

Baystate Medical Center, 759 Chestnut Street, Springfield, MA

INSIGHT Genomics Study to collect DNA of people with the flu

The purpose of this study is to obtain DNA of people who may have the flu in order to better understand the gene response to those that have a high risk of getting the flu.

Armando Paez, MD
Infection

Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199

Recruiting

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

The purpose of this study is to compare the effects, good and/or bad, of two different therapies that include combinations of the drugs rituximab, fludarabine, cyclophosphamide and ibrutinib.
Syed Ali, MD
Cancer - Leukemia, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active

Improving Outcome in Neonatal Abstinence Syndrome: a study to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb

The purpose of this research study is to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb and evaluate the effects of treatment on long-term neurodevelopmental outcome at 18 months of age. The goal is to compare the two most commonly used drugs and see which requires fewer days in the hospital to complete treatment.  The study will also determine if genetic variations contribute to the severity of NAS.

Rachana Singh, MD
Pediatrics

Baystate Children's Hospital
759 Chestnut Street
Springfield, MA 01199

Active

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

Joanna Luty, MD
Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Page 4 of 8 | Results 31 - 40 of 73